While there is insufficient data to demonstrate the long-term benefits and patient outcomes as a result of incorporated genomic sequencing in patients with PTPR, we do know that the immediate impact of identifying a PTEN germline pathogenic variant has resulted in genetic testing in immediate family members and an awareness and vigilance to screen sooner and more frequently for cancer. Here, PTPRR is linked to cancer.